VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JBI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JBIJanus International Group, Inc.
$5.19$708M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. JBI
  4. Financial Ratios

Janus International Group, Inc. (JBI) Financial Ratios

Latest Ratios: P/E Ratio 14.0x · EV/EBITDA 7.2x · ROE 9.9%. (2019–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

JBI Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Market Cap$708M$926M$1.1B$1.9B$1.4B$1.4B$1.5B$423M
Enterprise Value$1.1B$1.4B$1.6B$2.4B$2.0B$2.1B$2.0B$1.0B
P/E Ratio →14.0317.9715.0214.1813.0431.3025.5081.67
P/S Ratio0.801.051.111.801.371.822.660.75
P/B Ratio1.261.622.053.693.725.0910.371.37
P/FCF6.218.137.969.7817.5324.8515.46—
P/OCF5.076.646.928.9215.7818.2414.48—

P/E links to full P/E history page with 30-year chart

JBI EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
EV / Revenue—1.531.632.261.992.763.721.86
EV / EBITDA7.188.568.248.479.0315.8715.9929.94
EV / EBIT10.1311.9710.479.9410.8524.8721.48198.83
EV / FCF—11.8811.7312.3125.4937.6921.58—

JBI Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Gross Margin38.8%38.8%41.3%42.2%35.8%33.5%37.1%34.8%
Operating Margin12.7%12.7%15.2%23.0%18.4%12.3%17.2%-0.0%
Net Profit Margin6.1%6.1%7.3%12.7%10.6%5.8%10.4%0.9%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
ROE9.9%9.9%13.6%30.3%33.5%21.4%25.3%1.7%
ROA4.1%4.1%5.3%10.4%9.0%4.4%9.3%1.5%
ROIC8.3%8.3%10.8%18.2%14.2%8.2%8.6%-0.0%
ROCE9.5%9.5%12.5%21.4%17.9%10.5%16.8%-0.1%

JBI Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Debt / Equity1.091.091.261.281.902.684.432.04
Debt / EBITDA3.933.933.432.343.175.514.8917.96
Net Debt / Equity—0.750.970.951.692.634.112.03
Net Debt / EBITDA2.712.712.651.742.825.414.5417.89
Debt / FCF—3.763.772.537.9712.846.13—
Interest Coverage3.083.083.024.054.462.532.64—

JBI Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Current Ratio3.543.542.822.662.381.531.775.84
Quick Ratio3.043.042.432.381.941.121.50-54.37
Cash Ratio1.631.631.090.990.510.090.485.25
Asset Turnover—0.680.740.790.800.670.631.62
Inventory Turnover9.249.2410.6212.749.678.8113.6513.08
Days Sales Outstanding—55.9360.4876.6069.7163.5057.5354.20

JBI Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Dividend Yield—————0.3%3.4%16.9%
Payout Ratio—————9.6%86.1%1386.5%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Earnings Yield7.1%5.6%6.7%7.0%7.7%3.2%3.9%1.2%
FCF Yield16.1%12.3%12.6%10.2%5.7%4.0%6.5%—
Buyback Yield2.2%1.7%7.4%0.0%0.0%0.0%0.0%48.7%
Total Shareholder Yield2.2%1.7%7.4%0.0%0.0%0.3%3.4%65.6%
Shares Outstanding—$139M$145M$147M$147M$109M$136M$43M

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Cyclical demand and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Market Pricing Reflects Cyclical Uncertainty

According to current market data, JBI trades at a P/E of 14.81 and a forward P/E of 9.97, suggesting that investors are pricing in significant earnings recovery despite the recent -8.26% revenue contraction observed in the company's most recent quarterly financial filings.

The discount relative to peers like Allegion suggests the market remains skeptical of the company's ability to sustain margins in a cooling construction environment. Investors should monitor whether the forward multiple reflects a realistic recovery or if the market is underestimating the duration of the current cyclical downturn.

Capital Efficiency Trends Show Decay

Based on reported financial statements, JBI's ROIC has trended downward from 4.9% in 2023Q4 to a marginal 1.4% in 2026Q1, indicating that the company is struggling to generate adequate returns on its invested capital as revenue growth remains persistently negative across the last ten quarters.

This decay in capital efficiency appears to be driven by the combination of margin compression and the potential over-capitalization of the business following its acquisitive growth phase. The inability to maintain returns above the cost of capital warrants further investigation into the long-term viability of recent capital allocation decisions.

Working Capital Cycles Remain Volatile

As reported in recent SEC filings, the company's cash conversion cycle has fluctuated between 52 and 77 days over the last ten quarters, reflecting the inherent difficulty in managing inventory and receivables during a period of sustained top-line contraction and shifting project-based demand.

The variability in the CCC suggests that JBI's working capital management is highly sensitive to the timing of large-scale installation projects. Investors should monitor whether the recent stabilization in DSO is a sign of improved collection discipline or merely a byproduct of reduced project volume.

Deleveraging Masks Underlying Operational Risk

Based on the most recent quarterly data, JBI's debt-to-equity ratio has plummeted to 0.01, a dramatic shift from the 1.19 level observed in 2023Q4, which suggests a significant, potentially non-recurring, deleveraging event that has fundamentally altered the company's balance sheet risk profile.

While this nominal leverage appears to provide a fortress-like cushion, it may obscure the underlying operational volatility that has seen net margins compress to 0.1%. Analysts should verify if this deleveraging is sustainable or if it reflects a temporary liquidity management strategy that could be reversed.

Misapplication of Standard Cyclical Multiples

The market frequently misapplies standard building-product P/E multiples to JBI, which obscures the unique, recurring revenue potential of the Noke smart-entry ecosystem and the counter-cyclical nature of the R3 retrofit program, as noted in recent institutional research regarding the firm's niche market dominance.

By treating JBI as a pure-play cyclical manufacturer, investors may be ignoring the structural shift toward higher-margin software-enabled services. A more appropriate valuation framework would adjust for the recurring revenue component of the Noke platform rather than relying solely on volatile, project-based earnings multiples.

Download Financial Ratios Data

Includes 30+ ratios · 7 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

JBI — Frequently Asked Questions

Quick answers to the most common questions about buying JBI stock.

What is Janus International Group, Inc.'s P/E ratio?

Janus International Group, Inc.'s current P/E ratio is 14.0x. The historical average is 28.4x. This places it at the 14th percentile of its historical range.

What is Janus International Group, Inc.'s EV/EBITDA?

Janus International Group, Inc.'s current EV/EBITDA is 7.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.7x.

What is Janus International Group, Inc.'s ROE?

Janus International Group, Inc.'s return on equity (ROE) is 9.9%. The historical average is 19.4%.

Is JBI stock overvalued?

Based on historical data, Janus International Group, Inc. is trading at a P/E of 14.0x. This is at the 14th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Janus International Group, Inc.'s profit margins?

Janus International Group, Inc. has 38.8% gross margin and 12.7% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Janus International Group, Inc. have?

Janus International Group, Inc.'s Debt/EBITDA ratio is 3.9x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.